Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the must-buy penny stocks to invest in now. Recursion Pharmaceuticals ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...

A conceptual breakdown exploring whether removing recursion improves reinforcement learning models, focusing on stability, ...

We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

In a first-of-its-kind finding, researchers at University of Iowa Health Care discovered that specific genetic sequences have ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.60, marking a -4% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.26%.

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...

A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled “Toward actionable interventions in ...